InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

ABEO Insider Trading

Insider Ownership Percentage: 5.40%
Insider Buying (Last 12 Months): $154,047.12
Insider Selling (Last 12 Months): $36,199.24

Abeona Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Abeona Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abeona Therapeutics Share Price & Price History

Current Price: $5.98
Price Change: ▲ Price Increase of +0.19 (3.28%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for ABEO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

Abeona Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2024Leila AllandDirectorBuy11,000$4.71$51,810.0082,857View SEC Filing Icon  
4/26/2024Faith L CharlesDirectorBuy7,550$3.28$24,764.0078,323View SEC Filing Icon  
4/25/2024Brendan M. O'MalleySVPBuy8,600$3.24$27,864.00188,718View SEC Filing Icon  
4/25/2024Joseph Walter VazzanoCFOBuy5,608$3.14$17,609.12233,868View SEC Filing Icon  
4/25/2024Vishwas SeshadriCEOBuy10,000$3.20$32,000.00538,260View SEC Filing Icon  
1/17/2024Mark AlvinoDirectorSell7,084$5.11$36,199.2462,816View SEC Filing Icon  
9/27/2023Christine Berni SilversteinDirectorSell6,330$3.91$24,750.3087,884View SEC Filing Icon  
9/27/2023Vishwas SeshadriCEOBuy20,000$4.07$81,400.00521,731View SEC Filing Icon  
9/20/2023Michael AmorosoDirectorSell327$3.90$1,275.30114,465View SEC Filing Icon  
9/18/2023Brendan M. O'MalleySVPBuy3,000$3.80$11,400.00187,421View SEC Filing Icon  
6/20/2023Michael AmorosoDirectorSell338$4.45$1,504.10114,792View SEC Filing Icon  
3/20/2023Michael AmorosoDirectorSell268$2.33$624.4456,441View SEC Filing Icon  
3/3/2023Michael AmorosoDirectorSell1,002$2.38$2,384.7656,709View SEC Filing Icon  
12/9/2022Brendan M. O'MalleySVPBuy5,869$3.13$18,369.9793,830View SEC Filing Icon  
11/18/2022Brendan M. O'MalleySVPBuy7,500$3.99$29,925.0087,961View SEC Filing Icon  
11/18/2022Joseph Walter VazzanoCFOBuy2,500$4.00$10,000.0095,250View SEC Filing Icon  
6/6/2022Mark AlvinoDirectorSell35,000$0.16$5,600.0047,181View SEC Filing Icon  
12/6/2021Brendan M. O'MalleySVPSell8,880$0.57$5,061.60View SEC Filing Icon  
See Full Table
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Abeona Therapeutics (NASDAQ:ABEO)

80.56% of Abeona Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ABEO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Abeona Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC55,000$0.35M0.0%-28.0%0.127%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC465,317$2.94M0.0%+21.7%1.074%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC55,000$0.35M0.0%-28.0%0.127%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd25,301$0.16M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC13,216$84K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/15/2024Western Standard LLC1,698,097$10.73M10.1%+7.0%3.921%Search for SEC Filing on Google Icon
11/15/2024State Street Corp159,295$1.01M0.0%-1.6%0.368%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC583,593$3.69M0.5%-24.1%1.347%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC861,301$5.44M0.0%-13.0%1.989%Search for SEC Filing on Google Icon
11/13/2024Propel Bio Management LLC624,022$3.94M2.3%-50.0%1.441%Search for SEC Filing on Google Icon
11/12/2024Citigroup Inc.616,668$3.90M0.0%+10.1%1.424%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.23,850$0.15M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP96,092$0.61M0.0%+54.3%0.222%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.1,832,000$11.58M7.3%+4.7%4.472%Search for SEC Filing on Google Icon
10/25/2024abrdn plc326,995$2.07M0.0%+158.8%0.798%Search for SEC Filing on Google Icon
8/13/2024Simplify Asset Management Inc.408,584$1.73M0.1%N/A0.997%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC503,293$2.13M0.0%+581.6%1.229%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp121,453$0.52M0.0%+2.0%0.297%Search for SEC Filing on Google Icon
7/12/2024Rosalind Advisors Inc.1,750,000$7.42M5.4%N/A4.272%Search for SEC Filing on Google Icon
5/17/2024Western Standard LLC1,361,489$9.87M4.7%+68.5%4.978%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC12,634$91K0.0%N/A0.046%Search for SEC Filing on Google Icon
2/12/2024AIGH Capital Management LLC787,769$3.95M1.6%-30.6%3.180%Search for SEC Filing on Google Icon
2/9/2024Worth Venture Partners LLC196,439$0.98M0.5%-30.2%0.793%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC39,757$0.20M0.0%N/A0.160%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC281,280$1.18M0.7%+76.6%1.136%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.3,249,994$13.68M0.0%+84.5%13.126%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC153,930$0.65M0.0%N/A0.622%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC1,135,252$4.78M2.3%+77.7%4.585%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.450,000$1.89M0.0%+125.0%1.817%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC371,276$1.56M0.0%+100.0%1.499%Search for SEC Filing on Google Icon
11/1/2023Simplex Trading LLC14,128$59K0.0%+1,889.9%0.057%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC32,171$0.13M0.0%N/A0.171%Search for SEC Filing on Google Icon
5/11/2023Knott David M Jr160,000$0.45M0.2%+6.7%0.897%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC652,174$2.01M0.7%+363.7%3.796%Search for SEC Filing on Google Icon
2/15/2023Nantahala Capital Management LLC272,731$4.19M0.3%N/A1.587%Search for SEC Filing on Google Icon
2/14/2023EcoR1 Capital LLC1,086,956$3.35M0.1%N/A6.327%Search for SEC Filing on Google Icon
2/13/2023Knott David M Jr150,000$0.46M0.2%N/A0.873%Search for SEC Filing on Google Icon
11/15/2022Knoll Capital Management LLC88,629$0.27M0.2%-96.0%1.490%Search for SEC Filing on Google Icon
11/10/2022Phoenix Holdings Ltd.11,874$35K0.0%-96.0%0.200%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC5,025,100$1.58M0.4%+341.9%3.410%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.219,587$69K0.0%-93.0%0.149%Search for SEC Filing on Google Icon
2/14/2022Knoll Capital Management LLC2,215,740$0.65M0.4%-22.5%2.174%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.3,200,000$1.08M0.0%N/A3.140%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP788,085$0.27M0.0%+2,254.9%0.773%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC236,681$78K0.0%N/A0.232%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC1,137,274$0.38M0.1%N/A1.116%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA1,854,536$0.63M0.0%+1,166,274.8%1.820%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.3,127,813$1.05M0.0%+876.7%3.069%Search for SEC Filing on Google Icon
11/16/2021ACT Capital L.L.C.278,000$0.31M0.2%N/A0.275%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.325,000$0.36M0.0%N/A0.321%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP33,466$37K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,630,310$1.83M0.0%-1.2%1.611%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.320,235$0.36M0.0%+394.3%0.316%Search for SEC Filing on Google Icon
8/18/2021Meitav Dash Investments Ltd.122,000$0.19M0.0%+24.5%0.121%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC1,370,101$2.14M0.0%N/A1.353%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC24,764$39K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP38,599$60K0.0%N/A0.038%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.35,285$56K0.0%-78.5%0.035%Search for SEC Filing on Google Icon
8/16/2021State Street Corp309,402$0.48M0.0%-78.6%0.306%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd199,700$0.31M0.1%N/A0.197%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.329,538$0.52M0.0%+145.3%0.326%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp137,346$0.21M0.0%-78.1%0.136%Search for SEC Filing on Google Icon
8/13/2021Kore Private Wealth LLC77,459$0.12M0.0%N/A0.077%Search for SEC Filing on Google Icon
8/13/2021Qube Research & Technologies Ltd22,572$35K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC657,021$1.02M0.0%-40.8%0.649%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.3,727,536$5.82M0.0%+6.6%3.682%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd76,941$0.12M0.0%N/A0.076%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP177,147$0.28M0.0%-18.4%0.175%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.2,022,004$3.15M0.0%+5.7%1.997%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC179,300$0.28M0.0%N/A0.177%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp97,894$0.15M0.0%-64.3%0.097%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,649,387$2.57M0.0%-66.9%1.629%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG400,558$0.63M0.0%-8.8%0.396%Search for SEC Filing on Google Icon
8/10/2021Principal Financial Group Inc.22,746$35K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners18,506$29K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/5/2021Los Angeles Capital Management LLC77,170$0.12M0.0%-83.3%0.076%Search for SEC Filing on Google Icon
8/5/2021Meitav Dash Investments Ltd.122,000$0.19M0.0%+24.5%0.121%Search for SEC Filing on Google Icon
8/4/2021Russell Investments Group Ltd.931,964$1.45M0.0%+330.6%0.921%Search for SEC Filing on Google Icon
8/4/2021Migdal Insurance & Financial Holdings Ltd.112,859$0.18M0.0%+21.2%0.111%Search for SEC Filing on Google Icon
5/20/2021Axiom Investment Management LLC32,500$61K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC56,225$0.11M0.0%-52.4%0.057%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC13,302$25K0.0%-78.6%0.013%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley529,753$1M0.0%+193.1%0.535%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC62,782$0.12M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC1,118,934$2.10M0.0%+254.0%1.130%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.134,359$0.25M0.0%+173.9%0.136%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP217,068$0.41M0.0%-18.8%0.219%Search for SEC Filing on Google Icon
5/13/2021QS Investors LLC325,000$0.61M0.0%+51.2%0.328%Search for SEC Filing on Google Icon
5/13/2021Axiom Investment Management LLC32,500$61K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC50,598$95K0.0%-37.7%0.051%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC522,282$0.98M0.0%-60.5%0.527%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp627,177$1.18M0.0%-9.1%0.633%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,109,189$2.09M0.0%+5.1%1.120%Search for SEC Filing on Google Icon
5/12/2021Financial Engines Advisors L.L.C.21,445$40K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.1,913,541$3.60M0.0%+193.1%1.932%Search for SEC Filing on Google Icon
5/12/2021Panagora Asset Management Inc.19,812$37K0.0%+657.6%0.020%Search for SEC Filing on Google Icon
5/11/2021Boston Private Wealth LLC19,500$37K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund28,300$53K0.0%-48.1%0.029%Search for SEC Filing on Google Icon
5/11/2021Vontobel Holding Ltd.80,000$0.15M0.0%N/A0.081%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.4,980,925$9.36M0.0%+21.8%5.029%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Abeona Therapeutics logo
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering gene therapy products for severe and life-threatening rare diseases. The company's lead programs are EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102, which are AAV based gene therapies for Sanfilippo syndrome type A; and ABO-101, an adeno-associated virus (AAV) based gene therapies for Sanfilippo syndrome type B. It is also developing ABO-201 gene therapy for juvenile Batten disease; ABO-202 gene therapy for treatment of infantile Batten disease; EB-201 for for epidermolysis bullosa (EB); ABO-301 for Fanconi anemia disorder; and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. Further, it is involved in marketing MuGard, a mucoadhesive oral wound rinse for the management of mucositis, stomatitis, aphthous ulcers, and traumatic ulcers. Abeona Therapeutics Inc. has collaborations with EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation that focus on gene therapy treatments for EB; and Brammer Bio for commercial translation of ABO-102. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas.
Read More on Abeona Therapeutics

Today's Range

Now: $5.98
Low: $5.76
High: $6.17

50 Day Range

MA: $6.19
Low: $5.33
High: $6.74

52 Week Range

Now: $5.98
Low: $3.05
High: $9.01

Volume

387,598 shs

Average Volume

337,736 shs

Market Capitalization

$259.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52

Who are the company insiders with the largest holdings of Abeona Therapeutics?

Abeona Therapeutics' top insider shareholders include:
  1. Vishwas Seshadri (CEO)
  2. Joseph Walter Vazzano (CFO)
  3. Brendan M O'malley (SVP)
  4. Michael Amoroso (Director)
  5. Christine Berni Silverstein (Director)
  6. Leila Alland (Director)
  7. Faith L Charles (Director)
  8. Mark Alvino (Director)
Learn More about top insider investors at Abeona Therapeutics.

Who are the major institutional investors of Abeona Therapeutics?

Abeona Therapeutics' top institutional investors include:
  1. Rosalind Advisors Inc. — 4.47%
  2. Western Standard LLC — 3.92%
  3. Walleye Capital LLC — 1.99%
  4. Propel Bio Management LLC — 1.44%
  5. Citigroup Inc. — 1.42%
  6. Ikarian Capital LLC — 1.35%
Learn More about top institutional investors of Abeona Therapeutics stock.

Which institutional investors are selling Abeona Therapeutics stock?

In the last quarter, ABEO stock was sold by these institutional investors:
  1. Propel Bio Management LLC
  2. Ikarian Capital LLC
  3. Walleye Capital LLC
  4. Barclays PLC
  5. Barclays PLC
  6. State Street Corp

Which institutional investors are buying Abeona Therapeutics stock?

Within the previous quarter, ABEO stock was purchased by institutional investors including:
  1. abrdn plc
  2. Western Standard LLC
  3. Geode Capital Management LLC
  4. Rosalind Advisors Inc.
  5. Citigroup Inc.
  6. GSA Capital Partners LLP
  7. XTX Topco Ltd
  8. Charles Schwab Investment Management Inc.
Within the previous year, these company insiders have bought Abeona Therapeutics stock:
  1. Vishwas Seshadri (CEO)
  2. Joseph Walter Vazzano (CFO)
  3. Brendan M O'malley (SVP)
  4. Michael Amoroso (Director)
  5. Christine Berni Silverstein (Director)
Learn More investors buying Abeona Therapeutics stock.
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.